These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29557182)

  • 41. Identification of hallmarks of lung adenocarcinoma prognosis using whole genome sequencing.
    Liu L; Huang J; Wang K; Li L; Li Y; Yuan J; Wei S
    Oncotarget; 2015 Nov; 6(35):38016-28. PubMed ID: 26497366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.
    Nakamura H; Ichikawa T; Nakasone S; Miyoshi T; Sugano M; Kojima M; Fujii S; Ochiai A; Kuwata T; Aokage K; Suzuki K; Tsuboi M; Ishii G
    Lung Cancer; 2018 Jan; 115():56-63. PubMed ID: 29290263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
    Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
    Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discordant human epidermal growth factor receptor 2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis.
    Hedner C; Tran L; Borg D; Nodin B; Jirström K; Eberhard J
    Histopathology; 2016 Jan; 68(2):230-40. PubMed ID: 26016514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
    Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
    Lin YL; Wang YL; Ma JG; Li WP
    J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.
    Cappuzzo F; Hirsch FR; Rossi E; Bartolini S; Ceresoli GL; Bemis L; Haney J; Witta S; Danenberg K; Domenichini I; Ludovini V; Magrini E; Gregorc V; Doglioni C; Sidoni A; Tonato M; Franklin WA; Crino L; Bunn PA; Varella-Garcia M
    J Natl Cancer Inst; 2005 May; 97(9):643-55. PubMed ID: 15870435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer.
    Yoon HY; Kim YJ; Kim JS; Kim YW; Kang HW; Kim WT; Yun SJ; Ryu KH; Lee SC; Kim WJ
    Oncol Rep; 2016 Feb; 35(2):1195-203. PubMed ID: 26575865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer.
    Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY
    Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations.
    Peretti U; Ferrara R; Pilotto S; Kinspergher S; Caccese M; Santo A; Brunelli M; Caliò A; Carbognin L; Sperduti I; Garassino M; Chilosi M; Scarpa A; Tortora G; Bria E
    Respir Res; 2016 Aug; 17(1):105. PubMed ID: 27561692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
    Meng H; Li W; Boardman LA; Wang L
    BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients.
    Goltz D; Holmes EE; Gevensleben H; Sailer V; Dietrich J; Jung M; Röhler M; Meller S; Ellinger J; Kristiansen G; Dietrich D
    Oncotarget; 2016 Aug; 7(33):53309-53320. PubMed ID: 27462860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KLF15 suppresses cell growth and predicts prognosis in lung adenocarcinoma.
    Wang X; He M; Li J; Wang H; Huang J
    Biomed Pharmacother; 2018 Oct; 106():672-677. PubMed ID: 29990857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.
    Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM; Huang SF
    PLoS One; 2016; 11(10):e0164870. PubMed ID: 27764170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
    Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
    Takahashi Y; Iwaya T; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Takano Y; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Jan; 21(1):205-12. PubMed ID: 24046120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro.
    Lee E; Jin D; Lee BB; Kim Y; Han J; Shim YM; Kim DH
    BMC Cancer; 2015 Dec; 15():982. PubMed ID: 26681199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.
    Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T
    Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
    Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
    Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy.
    Gevensleben H; Holmes EE; Goltz D; Dietrich J; Sailer V; Ellinger J; Dietrich D; Kristiansen G
    Oncotarget; 2016 Nov; 7(48):79943-79955. PubMed ID: 27835597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.